Polymorphism of alpha-1-antitrypsin in hematological malignancies
2009

Alpha-1-antitrypsin Polymorphism in Blood Cancer

Sample size: 423 publication 10 minutes Evidence: moderate

Author Information

Author(s): Aleksandra Topic, Zorica Juranic, Svetislav Jelic, Ivana Golubicic

Primary Institution: Institute for Oncology and Radiology of Serbia

Hypothesis

Is there an association between alpha-1-antitrypsin polymorphism and hematological malignancies?

Conclusion

The study found a higher frequency of PiM1 homozygotes and PiM1 alleles in patients with hematological malignancies compared to healthy controls.

Supporting Evidence

  • The study included 151 patients with hematological malignancies and 272 healthy controls.
  • AAT phenotyping was performed using isoelectric focusing.
  • Significantly higher frequencies of PiM1 homozygotes and PiM1 alleles were found in patients compared to controls.

Takeaway

This study looked at a protein called alpha-1-antitrypsin in people with blood cancers and found that certain types of this protein were more common in those patients than in healthy people.

Methodology

Isoelectric focusing was used to identify AAT phenotypes in serum samples from patients and healthy controls.

Limitations

The study only included patients from specific institutions, which may limit the generalizability of the findings.

Participant Demographics

151 patients (119 males, 32 females, aged 21-69) and 272 healthy controls (221 males, 51 females, aged 20-65).

Statistical Information

P-Value

0.037

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1415-47572009005000085

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication